Trends of antihypertensive, antidiabetic, and non-steroidal anti-inflammatory drugs use among the Health Workers Cohort Study, Mexico 2004 to 2018.

Abstract

<title>Abstract</title> <italic>Background</italic> Hypertension and type 2 diabetes (T2D) are the most prevalent non-communicable diseases in Mexico and worldwide. According to international practice management guidelines, the principal chronic management therapy is daily oral medication. <italic>Aim</italic> We aim to describe the trends of antihypertensive, antidiabetic, and non-steroidal anti-inflammatory (NSAID) drugs use among the Mexican adult population from 2004-2018. <italic>Methods</italic> We analyzed data from the Health Workers Cohort Study (HWCS) for males and females aged <underline>&gt;</underline> 18 years. We calculated the prevalence of chronic diseases and utilization for every kind of antihypertensive, antidiabetic, and NSAIDs (measured by self-reported utilization) at baseline and two follow up (2004, 2010, and 2017). Trends were analyzed using Fisher’s exact test. <italic>Results</italic> Hypertension prevalence increased from 19.8 to 30.3%, higher than T2D prevalence from 7.0 to 12.8% through fourteen years of follow-up. Like the self-reported dual therapy, the proportion of patients using beta-blockers and angiotensin II receptor blockers increased. Regarding T2D, the prevalence of metformin utilization increased to 83.9%. The utilization of common NSAIDs, mainly for muscular pain, remained around 13 to 16%. <italic>Conclusions</italic> Our findings showed a changing prevalence of drug utilization for hypertension and T2D between 2004 and 2018 and consistent use of NSAIDs in the adult Mexican population.